Upregulation of Phosphodiesterase type 5 in the Hyperplastic Prostate
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/srep17888.pdf
Reference34 articles.
1. Garraway, W. M., Collins, G. N. & Lee, R. J. High prevalence of benign prostatic hypertrophy in the community. Lancet 338, 469–71 (1991).
2. Chute, C. G. et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol 150, 85–9 (1993).
3. Oelke, M. et al. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol 64, 118–40 (2013).
4. McVary, K. T. et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 185, 1793–1803 (2011).
5. Wang, X. et al. Comparative Effectiveness of Oral Drug Therapies for Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia: A Systematic Review and Network Meta-Analysis. PLoS One 9, e107593 (2014).
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Activation of the cGMP/PKG/ERK signaling pathway associated with PDE5Is inhibits fibroblast activation by downregulating autophagy in early progressive benign prostatic hyperplasia;World Journal of Urology;2024-05-18
2. Alteration of the Expression and Functional Activities of Myosin II Isoforms in Enlarged Hyperplastic Prostates;Journal of Personalized Medicine;2024-04-01
3. S100A4 modulates cell proliferation, apoptosis and fibrosis in the hyperplastic prostate;The International Journal of Biochemistry & Cell Biology;2024-04
4. Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway;International Journal of Molecular Sciences;2023-03-03
5. Beyond Erectile Dysfunction: cGMP-Specific Phosphodiesterase 5 Inhibitors for Other Clinical Disorders;Annual Review of Pharmacology and Toxicology;2023-01-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3